A Phase 2 Placebo-Controlled, Randomized, Double-Blind Clinical Study To Assess The Efficacy, Safety And Tolerability Of Two Doses Of Pulsed, Inhaled Nitric Oxide (ino) In Patients With Who Group 1 Pulmonary Arterial Hypertension (pah)
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要